AMA-002

N/A

Report date: 2023/01/31 18:33:21

Base Information

Drug NameAMA-002
Drug Alias NameAMA-002
ClassificationCell and gene therapy > Gene therapyVaccines
Mechanisms of ActionGene transferenceImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmarna Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesAmarna Therapeutics BV
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A